Hyperfine Announces Peer-Reviewed Publication Of NEURO PMR Study In Journal Of Neuroimaging
Peer-reviewed clinical results and strong patient preference support growing use across neurology practices and emerging brain health applicationsHyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology
Hyperfine's brain-scanning machine got approved by scientists who checked their work and found it works well. This kind of proof helps doctors trust using it more, which could mean more hospitals buy it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.